These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Comparative thrombolytic properties of tissue-type plasminogen activator and of a plasminogen activator inhibitor-1-resistant glycosylation variant, in a combined arterial and venous thrombosis model in the dog. Collen D; Stassen JM; Yasuda T; Refino C; Paoni N; Keyt B; Roskams T; Guerrero JL; Lijnen HR; Gold HK Thromb Haemost; 1994 Jul; 72(1):98-104. PubMed ID: 7974384 [TBL] [Abstract][Full Text] [Related]
4. Successful local thrombolysis of an acutely thrombosed AV fistula by recombinant human tissue plasminogen activator. Vlassopoulos D; Magana P; Logothetis E; Hadjiconstantinou V Nephrol Dial Transplant; 1993; 8(4):380-1. PubMed ID: 8390026 [No Abstract] [Full Text] [Related]
5. Successful treatment of a catheter-related right atrial thrombosis with recombinant tissue plasminogen activator and heparin. Cesaro S; Paris M; Corrò R; Svaluto G; Zanon GF; Gamba P; Milanesi O; Messina C; Zanesco L Support Care Cancer; 2002 Apr; 10(3):253-5. PubMed ID: 11904791 [TBL] [Abstract][Full Text] [Related]
6. Local thrombolysis with recombinant tissue plasminogen activator for thrombosed vascular access in hemodialysis patients. Vlassopoulos D; Logothetis E; Arvanitis D; Noussias C; Magana P; Katopodis K; Hadjiconstantinou V Clin Nephrol; 1996 Jul; 46(1):77-8. PubMed ID: 8832159 [No Abstract] [Full Text] [Related]
7. Thrombolytic therapy due to thrombus formation associated with left ventricular assist devices. Rothenburger M; Schmid C; Huelksen G; Loeher A; Scheld HH J Heart Lung Transplant; 2005 Dec; 24(12):2305. PubMed ID: 16364888 [No Abstract] [Full Text] [Related]
8. Thrombolysis of a neonatal brachial artery thrombosis with tissue plasminogen activator. Grieg A J Perinatol; 1998; 18(6 Pt 1):460-2. PubMed ID: 9848761 [TBL] [Abstract][Full Text] [Related]
10. Thrombolytic treatment with tissue-type plasminogen activator (t-PA) containing liposomes in rabbits: a comparison with free t-PA. Heeremans JL; Prevost R; Bekkers ME; Los P; Emeis JJ; Kluft C; Crommelin DJ Thromb Haemost; 1995 Mar; 73(3):488-94. PubMed ID: 7667833 [TBL] [Abstract][Full Text] [Related]
11. The effect of 40 kHz ultrasound on tissue plasminogen activator-induced clot lysis in three in vitro models. Pieters M; Hekkenberg RT; Barrett-Bergshoeff M; Rijken DC Ultrasound Med Biol; 2004 Nov; 30(11):1545-52. PubMed ID: 15588966 [TBL] [Abstract][Full Text] [Related]
13. Thrombolytic and haemorrhagic effects of bolus doses of tissue-type plasminogen activator and a hybrid plasminogen activator with prolonged plasma half-life (K2tu-PA: CGP 42935). Agnelli G; Pascucci C; Nenci GG; Mele A; Bürgi R; Heim J Thromb Haemost; 1993 Aug; 70(2):294-300. PubMed ID: 8236138 [TBL] [Abstract][Full Text] [Related]
14. [Selective intraarterial axillar artery thrombolysis in a neonate: angiographic and thermographic serial time course]. Lachmann R; Dinter D; Schaible T; Düber C; Neff KW Klin Padiatr; 2005; 217(1):18-9. PubMed ID: 15640966 [TBL] [Abstract][Full Text] [Related]
15. A thrombosis model for evaluating thrombolytic agents in the guinea-pig: comparison of t-PA, scu-PA and a novel thrombolytic agent, staphylokinase, on thrombolytic activity. Hirata Y; Umemura K; Takiguchi Y; Uematsu T; Nakashima M Blood Coagul Fibrinolysis; 1993 Aug; 4(4):569-75. PubMed ID: 7692999 [TBL] [Abstract][Full Text] [Related]
16. Recommendations for tPA thrombolysis in children. On behalf of the Scientific Subcommittee on Perinatal and Pediatric Thrombosis of the Scientific and Standardization Committee of the International Society of Thrombosis and Haemostasis. Manco-Johnson MJ; Grabowski EF; Hellgreen M; Kemahli AS; Massicotte MP; Muntean W; Peters M; Schlegel N; Wang M; Nowak-Göttl U Thromb Haemost; 2002 Jul; 88(1):157-8. PubMed ID: 12152658 [No Abstract] [Full Text] [Related]
17. In vitro clot lysis as a potential indicator of thrombus resistance to fibrinolysis--study in healthy subjects and correlation with blood fibrinolytic parameters. Colucci M; Scopece S; Gelato AV; Dimonte D; Semeraro N Thromb Haemost; 1997 Apr; 77(4):725-9. PubMed ID: 9134650 [TBL] [Abstract][Full Text] [Related]
18. [Acute deep vein thrombosis of lower limbs treated by thrombolytic therapy with recombinant tissue-type plasminogen activator]. Wu JD; Guan H; Wang SH; Liu CW; Jin YF; Liu B; Ye W; Zeng R Zhonghua Yi Xue Za Zhi; 2005 Feb; 85(7):491-2. PubMed ID: 15854559 [No Abstract] [Full Text] [Related]
19. [Mobile thrombus in the right atrium and pulmonary embolism: efficacy of thrombolytic treatment with alteplase]. López-Haldón JE; Varela Aguilar JM; Martínez Martínez A; González de la Puente MA Med Clin (Barc); 1997 Feb; 108(5):198. PubMed ID: 9091727 [No Abstract] [Full Text] [Related]
20. Cerebral venous congestion as indication for thrombolytic treatment. Tsai FY; Kostanian V; Rivera M; Lee KW; Chen CC; Nguyen TH Cardiovasc Intervent Radiol; 2007; 30(4):675-87. PubMed ID: 17573553 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]